Sternberg CN - Search Results

1

Association of Survival Benefit With Docetaxel in Prostate Cancer and Total Number of Cycles Administered: A Post Hoc Analysis of the Mainsail Study.

de Morrée ES, Vogelzang NJ, Petrylak DP, Budnik N, Wiechno PJ, Sternberg CN, Doner K, Bellmunt J, Burke JM, Ochoa de Olza M, Choudhury A, Gschwend JE, Kopyltsov E, Flechon A, van As N, Houede N, Barton D, Fandi A, Jungnelius U, Li S, Li JS, de Wit R. de Morrée ES, et al. Among authors: sternberg cn. JAMA Oncol. 2017 Jan 1;3(1):68-75. doi: 10.1001/jamaoncol.2016.3000. JAMA Oncol. 2017. PMID: 27560549 Clinical Trial.

2

Gemcitabine in bladder cancer.

Sternberg CN. Sternberg CN. Semin Oncol. 2000 Feb;27(1 Suppl 2):31-9. Semin Oncol. 2000. PMID: 10697034 Review.

3

Gemcitabine, paclitaxel, pemetrexed and other newer agents in urothelial and kidney cancers.

Sternberg CN, Vogelzang NJ. Sternberg CN, et al. Crit Rev Oncol Hematol. 2003 Jun 27;46 Suppl:S105-15. doi: 10.1016/s1040-8428(03)00068-4. Crit Rev Oncol Hematol. 2003. PMID: 12850531 Review.

4

Chemotherapy for local treatment of bladder cancer.

Sternberg CN. Sternberg CN. Semin Radiat Oncol. 2005 Jan;15(1):60-5. doi: 10.1016/j.semradonc.2004.07.014. Semin Radiat Oncol. 2005. PMID: 15662609 Review.

5

Phase III trial of satraplatin, an oral platinum plus prednisone vs. prednisone alone in patients with hormone-refractory prostate cancer.

Sternberg CN, Whelan P, Hetherington J, Paluchowska B, Slee PH, Vekemans K, Van Erps P, Theodore C, Koriakine O, Oliver T, Lebwohl D, Debois M, Zurlo A, Collette L; Genitourinary Tract Group of the EORTC. Sternberg CN, et al. Oncology. 2005;68(1):2-9. doi: 10.1159/000084201. Epub 2005 Feb 28. Oncology. 2005. PMID: 15741753 Clinical Trial.

6

The medical management of prostate cancer: a multidisciplinary team approach.

Sternberg CN, Krainer M, Oh WK, Bracarda S, Bellmunt J, Ozen H, Zlotta A, Beer TM, Oudard S, Rauchenwald M, Skoneczna I, Borner MM, Fitzpatrick JM. Sternberg CN, et al. BJU Int. 2007 Jan;99(1):22-7. doi: 10.1111/j.1464-410X.2006.06477.x. Epub 2006 Sep 6. BJU Int. 2007. PMID: 16956362 Review. No abstract available.

7

Current indications for chemotherapy in prostate cancer patients.

Calabrò F, Sternberg CN. Calabrò F, et al. Among authors: sternberg cn. Eur Urol. 2007 Jan;51(1):17-26. doi: 10.1016/j.eururo.2006.08.013. Epub 2006 Aug 22. Eur Urol. 2007. PMID: 17007996 Review.

8

Effective chemotherapy for hormone-refractory prostate cancer (HRPC): present status and perspectives with taxane-based treatments.

Mancuso A, Oudard S, Sternberg CN. Mancuso A, et al. Among authors: sternberg cn. Crit Rev Oncol Hematol. 2007 Feb;61(2):176-85. doi: 10.1016/j.critrevonc.2006.09.001. Epub 2006 Oct 30. Crit Rev Oncol Hematol. 2007. PMID: 17074501 Review.

9

Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer.

Sternberg CN, Donat SM, Bellmunt J, Millikan RE, Stadler W, De Mulder P, Sherif A, von der Maase H, Tsukamoto T, Soloway MS. Sternberg CN, et al. Urology. 2007 Jan;69(1 Suppl):62-79. doi: 10.1016/j.urology.2006.10.041. Urology. 2007. PMID: 17280909 Review.

10

Perioperative chemotherapy in muscle-invasive bladder cancer to enhance survival and/or as a strategy for bladder preservation.

Sternberg CN. Sternberg CN. Semin Oncol. 2007 Apr;34(2):122-8. doi: 10.1053/j.seminoncol.2006.12.006. Semin Oncol. 2007. PMID: 17382795 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

448 results

Search Page